UN urges broader access to drugsBMJ 2016; 354 doi: http://dx.doi.org/10.1136/bmj.i5017 (Published 15 September 2016) Cite this as: BMJ 2016;354:i5017
- Anne Gulland
Drug companies and governments must do more to ensure access to drugs among the world’s poorest people, a United Nations report has urged.
The final report of the UN secretary general’s high level panel on access to medicines said that despite the improvements brought by medical innovation in the field of vaccines and antiretroviral drugs for HIV/AIDS over the past few decades, “millions of people continue to suffer and die from treatable conditions because of a lack of access to health technologies.”1
It said that investment in research and development (R&D) did not adequately …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial